RecruitingPhase 1Phase 2NCT06615752

Green Tea and Quercetin in Combination With Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Patients

A Phase I/II Study to Determine the Safety and Efficacy of a Combination of Green Tea and Quercetin With Docetaxel in Castration-resistant Prostate Cancer Patients


Sponsor

Charles Drew University of Medicine and Science

Enrollment

99 participants

Start Date

Oct 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to find out if taking natural products green tea and quercetin along with docetaxel chemotherapy improves the therapy of advanced prostate cancer, i.e., metastatic castration-resistant prostate cancer (mCRPC). It will also learn about the safety of this combination. Researchers will compare green tea plus quercetin to a placebo (a look-alike substance that contains no drug) in combination with docetaxel to see if green tea and quercetin works to improve the therapeutic effect of docetaxel.


Eligibility

Sex: MALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether combining two natural compounds — green tea extract and quercetin (found in many fruits and vegetables) — with standard docetaxel chemotherapy can improve outcomes for men with castration-resistant prostate cancer (cancer that has stopped responding to hormone therapy). Both compounds have shown potential anti-cancer properties in lab studies. **You may be eligible if...** - You are a man 18 years or older - You have been diagnosed with metastatic prostate cancer - Your cancer is castration-resistant (progressing despite hormone therapy) - You are scheduled to receive docetaxel chemotherapy **You may NOT be eligible if...** - You have severe liver problems (green tea extract can affect liver function) - You have had prior treatment with docetaxel - You have serious heart, kidney, or bleeding conditions - You are taking blood thinners or other medications that may interact Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGgreen tea and quercetin + docetaxel

green tea and quercetin supplements in combination with docetaxel infusion

DRUGPlacebo + docetaxel

Placebo will be given along with docetaxel chemotherapy


Locations(1)

Charles R. Drew University of Medicine and Science

Los Angeles, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06615752


Related Trials